Immune-related adverse events after 2 years in patients with advanced non-small-cell lung cancer receiving extended immune checkpoint inhibitor therapy.

被引：0
|
作者：
Elghawy, Omar
Barsouk, Adam
Sussman, Jonathan Henry
Davella, Christopher
Singh, Aditi Puri
Ciunci, Christine Agnes
Robinson, Kyle William
Kosteva, John A.
Langer, Corey J.
Cohen, Roger B.
Aggarwal, Charu
Marmarelis, Melina Elpi
Sun, Lova
机构：
[1] Penn Med Abramson Canc Ctr, Philadelphia, PA USA
[2] Univ Penn, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8551
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy
    Matsuo, Norikazu
    Azuma, Koichi
    Kojima, Takashi
    Ishii, Hidenobu
    Tokito, Takaaki
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1150 - 1158
  • [42] Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Huang, Derek De-Rui
    Liao, Bin-Chi
    Hsu, Wei-Hsun
    Yang, Ching-Yao
    Lin, Yen-Ting
    Wu, Shang-Gin
    Tsai, Tzu-Hsiu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Liao, Wei-Yu
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    Cheng, Ann-Lii
    Shen, Ying-Chun
    ONCOLOGY, 2024, 102 (04) : 318 - 326
  • [43] Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy
    Norikazu Matsuo
    Koichi Azuma
    Takashi Kojima
    Hidenobu Ishii
    Takaaki Tokito
    Kazuhiko Yamada
    Tomoaki Hoshino
    Investigational New Drugs, 2021, 39 : 1150 - 1158
  • [44] Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
    Burke, Michael
    Rashdan, Sawsan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy
    Burdett, Nikki
    Hsu, Kristin
    Xiong, Libo
    Tapia-Rico, Gonzalo
    Beckmann, Kerri
    Karapetis, Christos
    Brown, Michael P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (02) : E139 - E145
  • [46] Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    Del Carpio Huerta, L.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Genua Trullos, I.
    Tuneu Valls, L.
    Stantonyonge Sesnic, N.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruellal, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S485 - S486
  • [47] Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report
    Shantzer, Lindsey B.
    Dougherty, Sean C.
    Bolte, Fabian
    Melson, John W.
    Reed, Daniel R.
    Lynch, Alia C.
    Gentzler, Ryan D.
    Novicoff, Wendy
    Hall, Richard D.
    CLINICAL LUNG CANCER, 2022, 24 (02) : e60 - e64
  • [48] Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer
    Owen, Dwight H.
    Wei, Lai
    Bertino, Erin M.
    Edd, Thomas
    Villalona-Calero, Miguel A.
    He, Kai
    Shields, Peter G.
    Carbone, David P.
    Otterson, Gregory A.
    CLINICAL LUNG CANCER, 2018, 19 (06) : E893 - E900
  • [49] Musculoskeletal Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy: Single Center Experience
    Saygin, Didem
    Bastacky, Melissa
    Mascara, Gerard
    Brenner, Timothy L.
    Oddis, Chester
    Moghadam-Kia, Siamak
    Ascherman, Dana
    Davar, Diwakar
    Aggarwal, Rohit
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Lessons from Pharmacovigilance: Pulmonary Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
    Stephen W. Reese
    Eugene Cone
    Maya Marchese
    Brenda Garcia
    Wesley Chou
    Asha Ayub
    Kerry Kilbridge
    Gerald Weinhouse
    Quoc-Dien Trinh
    Lung, 2021, 199 : 199 - 211
12345